Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00126
|
|||||
Drug Name |
Adenine
|
|||||
Synonyms |
1,6-Dihydro-6-Imnopurine; 1,6-Dihydro-6-iminopurine; 1H-Purin-6-amine; 1H-Purin-6-amine (9CI); 1H-Purine, 6-amino; 2'-DEOXY-ADENOSINE-3'-5'-DIPHOSPHATE; 3,6-Dihydro-6-iminopurine; 4, Vitamin B; 6-Amino-1H-purine; 6-Amino-3H-purine; 6-Amino-7H-purine; 6-Amino-9H-purine; 6-Aminopurine; 7H-Purin-6-amine; 9H-Purin-6-amine; AD2; ADE; ALBB-005925; ANE; Adenin; Adenine (8CI); Adenine (JAN/USP); Adenine [JAN]; Adenine-8-14C; Adenine-ring; Adeninimine; B 4, Vitamin; Leuco-4; Leucon (TN); Pedatisectine B; Purine, 6; USAF CB-18; Vitamin B 4; Vitamin B4; Vitamin-B4
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Dietary shortage [ICD11: 5B7Z] | Approved | [1] | |||
Therapeutic Class |
Dietary supplement
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C5H5N5
|
|||||
Canonical SMILES |
C1=NC2=NC=NC(=C2N1)N
|
|||||
InChI |
InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)
|
|||||
InChIKey |
GFFGJBXGBJISGV-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 73-24-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 135.13 | Topological Polar Surface Area | 80.5 | ||
Heavy Atom Count | 10 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
-0.1
|
|||||
PubChem CID | ||||||
PubChem SID |
10317179
, 10322142
, 10534154
, 11341806
, 11361989
, 11364000
, 11364970
, 11366562
, 11367532
, 11369124
, 11370094
, 11371752
, 11373133
, 2101
, 2102
, 3135000
, 3447
, 5344002
, 5385494
, 540768
, 584702
, 585680
, 589178
, 610762
, 7847102
, 7885703
, 7885710
, 7885885
, 8025117
, 8025303
, 8144939
, 8150497
, 820745
, 822025
, 823157
, 823652
, 823885
, 825880
, 826914
, 827713
, 828509
, 828511
, 830162
, 830693
, 830719
, 830741
, 830750
, 832226
, 836808
, 841461
|
|||||
ChEBI ID |
ChEBI:16708
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | ANT3 | Transporter Info | Adenine nucleotide translocator 3 | Substrate | [2] | |
References | ||||||
1 | Clofarabine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells. Mol Biol Cell. 2007 Nov;18(11):4681-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.